07422739 is referenced by 83 patents and cites 48 patents.

Disclosed are chimeric, immunologically active, isolated, and radiolabeled antibodies directed against the CD20 antigen. The antibodies are useful for treating and diagnosing B cell disorders.

Title
Anti-CD20 antibodies
Application Number
9/911703
Publication Number
7422739 (B2)
Application Date
July 25, 2001
Publication Date
September 9, 2008
Inventor
William H Rastetter
Rancho Santa Fe
CA, US
Mitchell E Reff
San Diego
CA, US
Roland A Newman
San Diego
CA, US
Nabil Hanna
Rancho Santa Fe
CA, US
Darrell R Anderson
Escondido
CA, US
Agent
Sidley Austin
Assignee
Biogen Idec
MA, US
IPC
C07K 16/30
C07K 16/28
A61K 39/396
View Original Source